Source study found

Story checked

Your Blood May Predict How Well a Vaccine Will Work (opens in a new tab)

scitechdaily.com · 2026-09-17

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

4 supported
1 overstated
1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Your Blood May Predict How Well a Vaccine Will Work

scitechdaily.com · 2026-09-17

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

One claim overstates the study. Four of six check out. One claim the study doesn't address.

4 supported
1 overstated
1 not covered

Open claim evidence

The source study

Pre-vaccine sentinel antibodies predict blunted vaccine responses

Cell Press Blue · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedHidden antibody patterns in your blood may reveal how well your immune system will respond to a vaccine before you get the shot.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that pre-vaccination antimicrobial antibody patterns predicted/stratified COVID-19 post-vaccination antibody responses. However, the headline wording generalizes to “a vaccine” without specifying COVID-19; that outruns the paper evidence available here and also outruns the story body’s caveat that validation with other vaccines is needed.

Study evidence

In this cohort, blunted COVID-19 vaccine responses were more frequent in solid organ transplant recipients and individuals with multiple myeloma, autoimmune disease, inflammatory bowel disease, and HIV.

“we conducted a national longitudinal study of humoral immune responses to 185 antigens ... in 1,644 immunosuppressed patients and 2,445 healthy individuals before and after COVID-19 vaccination”

Study evidence

Pre-existing antibodies to specific common microbes (Staphylococcus aureus, respiratory syncytial virus, human respirovirus 3) consistently predicted post-vaccination SARS-CoV-2 antibody responses in both healthy and immunosuppressed populations.

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Claim 2 of 6Not coveredThe study analyzed 8,687 blood samples from 4,089 participants before and after COVID-19 vaccination, measuring antibodies against 185 antigens.View evidenceHide evidence

As stated8,687 blood samples; 4,089 participants; 185 antigens

Why this verdict

The abstract-level profile supports 4,089 participants, pre/post COVID-19 vaccination serology, and profiling across 185 antigens. It does not provide the stated 8,687 blood-sample count, so the full numerical claim cannot be verified at abstract depth.

Study evidence

“we conducted a national longitudinal study of humoral immune responses to 185 antigens ... in 1,644 immunosuppressed patients and 2,445 healthy individuals before and after COVID-19 vaccination”

Study evidence

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Claim 3 of 6SupportedIn a study led by Arizona State University, people with higher levels of certain preexisting antibodies tended to respond more strongly to COVID-19 vaccination.View evidenceHide evidence

Why this verdict

The paper profile reports that pre-existing antibodies to common microbes consistently predicted post-vaccination COVID-19 antibody responses in healthy and immunosuppressed populations, matching the story’s hedged associational framing. The supplied paper profile does not verify the Arizona State University leadership attribution, but the scientific substance of the claim is supported.

Study evidence

“we conducted a national longitudinal study of humoral immune responses to 185 antigens ... in 1,644 immunosuppressed patients and 2,445 healthy individuals before and after COVID-19 vaccination”

Study evidence

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Claim 4 of 6SupportedThe antibodies included ones against Staphylococcus aureus, RSV, and human respirovirus 3, and the researchers described them as "sentinel" antibodies that may indicate how readily the antibody-producing part of the immune system can respond.View evidenceHide evidence

Why this verdict

The abstract explicitly identifies pre-existing antibodies to Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3 as predictors and describes broadly prevalent antimicrobial antibodies as “sentinel antibodies” that may serve as biomarkers of system-level humoral immune competence.

Study evidence

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Claim 5 of 6SupportedA deep-learning model trained on the antibody data could help distinguish strong vaccine responders from weak responders.View evidenceHide evidence

Why this verdict

The paper profile states that the authors developed a deep-learning predictive model using global antimicrobial antibody profiles to stratify individuals by likelihood of blunted vaccine responses. The story’s hedged wording, “could help distinguish,” is consistent with this, although abstract-level evidence does not provide performance metrics.

Study evidence

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Study evidence

A deep-learning model using global antimicrobial antibody profiles stratified individuals by likelihood of a blunted post-vaccination antibody response.

“Using global antimicrobial antibody profiles, we developed a deep-learning predictive model that stratified individuals according to their likelihood of mounting blunted vaccine responses.”

Claim 6 of 6SupportedThe findings need validation in additional studies and with other vaccines before researchers can know whether they apply beyond COVID-19.View evidenceHide evidence

Why this verdict

The profile’s abstract-level limitations note missing external validation/generalizability information and limited model-evaluation detail. Because the evidence is confined to COVID-19 vaccination in the reported cohort, the story’s caveat that additional studies and other vaccines are needed before broader generalization is appropriate.

Study evidence

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

Study evidence

A deep-learning model using global antimicrobial antibody profiles stratified individuals by likelihood of a blunted post-vaccination antibody response.

“Using global antimicrobial antibody profiles, we developed a deep-learning predictive model that stratified individuals according to their likelihood of mounting blunted vaccine responses.”

Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

7 things the story did carry across

National longitudinal observational cohort of 1,644 immunosuppressed patients and 2,445 healthy individuals with pre- and post-COVID-19 vaccination antibody profiling.
Multiplex humoral profiling covered 185 antigens, including SARS-CoV-2, common microbial, and autoantigen targets.
Pre-existing antibodies to common microbes, including Staphylococcus aureus, RSV, and human respirovirus 3, predicted post-vaccination COVID-19 antibody responses and were framed as sentinel biomarkers.
Deep-learning model using global antimicrobial antibody profiles stratified individuals by likelihood of blunted vaccine response.
Blunted responses were more frequent in several immunosuppressed subgroups, but responses were heterogeneous and about 5–6% of healthy individuals mounted weak responses.
The study is observational/predictive rather than causal; antibody patterns are biomarkers or predictors, not proven causes of vaccine response strength.
Generalizability beyond the reported cohort and beyond COVID-19 vaccination remains uncertain at abstract depth.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCharacterize pre- vs post-COVID-19 vaccination humoral antibody responses across many antigens in a national longitudinal cohort of immunosuppressed patients and healthy individuals, and quantify heterogeneity/blunted responses by clinical group.longitudinal cohortExpand

In plain English

National longitudinal observational study measuring humoral antibody responses to 185 antigens (3 SARS-CoV-2, 157 common microbes, 25 autoantigens) before and after COVID-19 vaccination in 1,644 immunosuppressed patients and 2,445 healthy individuals. The study quantified heterogeneity in post-vaccination antibody responses across clinical subgroups, identified pre-existing antimicrobial antibodies that predicted post-vaccination responses, and developed a deep-learning model to stratify risk of blunted vaccine responses.

Key findings

In this cohort, blunted COVID-19 vaccine responses were more frequent in solid organ transplant recipients and individuals with multiple myeloma, autoimmune disease, inflammatory bowel disease, and HIV.
Responses were highly heterogeneous within every cohort; approximately 5–6% of healthy individuals mounted weak post-vaccination antibody responses.≈5–6% (healthy individuals)

“we conducted a national longitudinal study of humoral immune responses to 185 antigens ... in 1,644 immunosuppressed patients and 2,445 healthy individuals before and after COVID-19 vaccination”

2human in vivoIdentify specific pre-existing antimicrobial antibody levels (“sentinel antibodies”) that predict post-vaccination COVID-19 antibody responses across populations.observational predictor-outcome modeling; multiplex serology; deep-learning stratificationExpand

In plain English

In a national longitudinal study measuring antibodies to 185 antigens in 4,089 individuals (2,445 healthy; 1,644 immunosuppressed) before and after COVID-19 vaccination, the authors report that pre-existing antibodies to specific common microbes—including Staphylococcus aureus, respiratory syncytial virus (RSV), and human respirovirus 3—consistently predicted post-vaccination SARS-CoV-2 antibody responses across both healthy and immunosuppressed populations. Using global antimicrobial antibody profiles, they also developed a deep-learning model that stratified individuals by likelihood of mounting blunted vaccine responses.

Key findings

Pre-existing antibodies to specific common microbes (Staphylococcus aureus, respiratory syncytial virus, human respirovirus 3) consistently predicted post-vaccination SARS-CoV-2 antibody responses in both healthy and immunosuppressed populations.
Global antimicrobial antibody profiles were used to develop a deep-learning predictive model that stratified individuals by likelihood of mounting blunted COVID-19 vaccine antibody responses.

“Pre-existing antibodies to common microbes, including Staphylococcus aureus, respiratory syncytial virus, and human respirovirus 3, consistently predicted post-vaccination antibody responses in both healthy and immunosuppressed populations.”

What this piece can’t prove

Timing of post-vaccination sampling, assay performance characteristics, and definitions of 'blunted' or 'weak' responses are not specified.

3 further details could not be confirmed from the summary.

3in silicoDevelop and evaluate a deep-learning model using global antimicrobial antibody profiles to predict/stratify likelihood of blunted vaccine response before vaccination.deep learning predictive modelingExpand

In plain English

The authors report developing a deep-learning predictive model that uses global antimicrobial antibody profiles (multiplex measurements across 185 antigens) from a national longitudinal cohort (1,644 immunosuppressed and 2,445 healthy individuals) to stratify individuals by their likelihood of mounting a blunted antibody response to COVID-19 vaccination.

Key findings

A deep-learning model using global antimicrobial antibody profiles stratified individuals by likelihood of a blunted post-vaccination antibody response.

“Using global antimicrobial antibody profiles, we developed a deep-learning predictive model that stratified individuals according to their likelihood of mounting blunted vaccine responses.”

What this piece can’t prove

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer